InfuSystem Holdings (INFU) Cash & Equivalents Growth (1y) (2011 - 2026)
InfuSystem Holdings (INFU) Cash & Equivalents Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.57 Bn | 193.97 Bn | 7.27 Bn | -26.57% |
| 2 | Stryker | 127.25 Bn | 123.77 Bn | 4.50 Bn | 42.78% |
| 3 | Medtronic | 118.81 Bn | 109.59 Bn | 6.41 Bn | -12.13% |
| 4 | Boston Scientific | 73.35 Bn | 72.81 Bn | 3.85 Bn | 0.94% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -11.19% |
| 6 | Dexcom | 34.28 Bn | 32.34 Bn | 830.00 Mn | -4.66% |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.64 Bn | 2.18 Bn | -44.03% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 19.49% |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | 72.43% |
| 10 | InfuSystem Holdings | 244.07 Mn | 243.10 Mn | 21.41 Mn | 33.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 33.89% |
| Mar 31, 2026 | 39.84% |
| Dec 31, 2025 | 504.55% |
| Sep 30, 2025 | 151.32% |
| Jun 30, 2025 | 393.15% |
| Mar 31, 2025 | 83.21% |
| Dec 31, 2024 | 128.14% |
| Sep 30, 2024 | 136.02% |
| Jun 30, 2024 | 8.96% |
| Mar 31, 2024 | 221.09% |
| Dec 31, 2023 | 40.00% |
| Sep 30, 2023 | -55.65% |
| Jun 30, 2023 | -56.91% |
| Mar 31, 2023 | -36.79% |
| Dec 31, 2022 | -11.29% |
| Sep 30, 2022 | 120.00% |
| Jun 30, 2022 | 89.63% |
| Mar 31, 2022 | -85.33% |
| Dec 31, 2021 | -98.07% |
| Sep 30, 2021 | -91.49% |